Skip to Content

WPI 3355 (Nateglinide 120 mg)

Pill with imprint WPI 3355 is Pink, Capsule-shape and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc..

Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3355

Nateglinide

Imprint
WPI 3355
Strength
120 mg
Color
Pink
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories Inc.
National Drug Code (NDC)
00591-3355
Inactive Ingredients
silicon dioxide, fumaric acid, hypromellose 2910 (3 mPa.s), lactose monohydrate, magnesium stearate, polysorbate 80, sodium starch glycolate type A potato, corn starch, titanium dioxide, hypromellose 2910 (6 mPa.s), FD&C Red No. 40, ferric oxide red, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.